Skip to main content
Retour
OHI logo

Omega Healthcare Investors, Inc.

Qualité des données : 100%
OHI
NYSE Real Estate REIT - Healthcare Facilities
44,73 €
▼ 0,11 € (-0,25%)
Cap. Boursière : 13,22B
Fourchette du Jour
44,61 € 45,42 €
Fourchette 52 Semaines
35,04 € 49,14 €
Volume
1 267 898
Moyenne 50J / 200J
45,90 € / 42,38 €
Clôture Précédente
44,84 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Real Estate (361 pairs)

Métrique Action Médiane du Secteur
P/E 22,4 11,1
P/B 2,6 0,8
ROE % 12,1 6,1
Net Margin % 49,3 19,9
Rev Growth 5Y % 3,0 7,0
D/E 0,8 0,9

Objectif de Cours des Analystes

Hold
49,14 € +9.9%
Low: 45,00 € High: 54,00 €
P/E Prévisionnel
22,6
BPA Prévisionnel
1,99 €
Croissance BPA (est.)
+0,0%
CA Est.
1,1 B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 0,00 €
0,00 € – 0,00 €
1,1 B 2
FY2029 1,95 €
1,86 € – 2,12 €
1,2 B 2
FY2028 2,02 €
1,66 € – 2,88 €
1,2 B 4

Points Clés

Revenue grew 3,04% annually over 5 years — modest growth
Earnings grew 45,23% over the past year
ROE of 12,14% — decent returns on equity
Net margin of 49,25% shows strong profitability
Generating 878,55M in free cash flow
PEG of 0,78 suggests growth is underpriced

Croissance

Revenue Growth (5Y)
3,04%
Revenue (1Y)13,95%
Earnings (1Y)45,23%
FCF Growth (3Y)22,18%

Qualité

Return on Equity
12,14%
ROIC5,96%
Net Margin49,25%
Op. Margin62,55%

Sécurité

Debt / Equity
0,82
Current Ratio3,46
Interest Coverage3,40

Valorisation

P/E Ratio
22,40
P/B Ratio2,55
EV/EBITDA23,28
Dividend Yield0,06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13,95% Revenue Growth (3Y) 12,32%
Earnings Growth (1Y) 45,23% Earnings Growth (3Y) 56,10%
Revenue Growth (5Y) 3,04% Earnings Growth (5Y) 9,09%
Profitability
Revenue (TTM) 1,20B Net Income (TTM) 590,11M
ROE 12,14% ROA 5,87%
Gross Margin 44,50% Operating Margin 62,55%
Net Margin 49,25% Free Cash Flow (TTM) 878,55M
ROIC 5,96% FCF Growth (3Y) 22,18%
Safety
Debt / Equity 0,82 Current Ratio 3,46
Interest Coverage 3,40 Dividend Yield 0,06%
Valuation
P/E Ratio 22,40 P/B Ratio 2,55
P/S Ratio 11,03 PEG Ratio 0,78
EV/EBITDA 23,28 Dividend Yield 0,06%
Market Cap 13,22B Enterprise Value 17,45B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,20B 1,05B 949,74M 878,24M 1,06B
Net Income 590,11M 406,33M 242,18M 426,93M 416,74M
EPS (Diluted) 1,94 1,55 1,00 1,80 1,75
Gross Profit 533,17M 1,04B 934,72M 862,74M 1,05B
Operating Income 749,44M 659,66M 488,97M 392,28M 566,17M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10,05B 9,90B 9,12B 9,41B 9,64B
Total Liabilities 4,61B 5,17B 5,36B 5,60B 5,53B
Shareholders' Equity 5,18B 4,54B 3,57B 3,61B 3,91B
Total Debt 4,26B 4,84B 5,07B 5,29B 5,25B
Cash & Equivalents 27,02M 518,34M 442,81M 297,10M 20,53M
Current Assets 2,06B 2,64B 2,23B 1,77B 1,81B
Current Liabilities 594,55M 328,19M 308,19M 334,29M 276,72M

Scores de Stratégies

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
#485 of 1052
46
#155 of 332
53

Activité Récente

Entré Cash Flow Compounder
Mar 24, 2026
Entré Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026